{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:12:33Z","timestamp":1792807953542,"version":"4.5.0"},"reference-count":48,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"unspecified","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022419","name":"National Institute for Health Research Southampton Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203319"],"award-info":[{"award-number":["NIHR203319"]}],"id":[{"id":"10.13039\/501100022419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1800801"],"award-info":[{"award-number":["2023YFA1800801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070588"],"award-info":[{"award-number":["82070588"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370577"],"award-info":[{"award-number":["82370577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["egastro"],"accepted":{"date-parts":[[2026,3,10]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasing health problem in the Asia-Pacific region, contributing significantly to morbidity and healthcare burden. This study provides a comprehensive analysis of the burden of MASLD across countries and territories in the Asia-Pacific region from 1990 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the Global Burden of Disease 2023 data set to assess the burden of MASLD in the Asia-Pacific region, calculating age-standardised prevalence, incidence, death and disability-adjusted life year (DALY) rates. Temporal trends, age-specific and sex-specific patterns, and the relationship between MASLD burden and Socio-demographic Index (SDI) were also analysed, along with regional variations driven by ageing, population growth and epidemiological changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2023, MASLD prevalence varied across the Asia-Pacific region, with the highest rates in Oceania (15\u2009360.55 per 100 000), Central Asia (15\u2009201.10 per 100 000), South-East Asia (15\u2009116.91 per 100 000) and East Asia (15\u2009042.06 per 100 000), and lower rates in Australasia (9336.02 per 100 000) and high-income regions (8654.71 per 100 000). Over the past three decades, MASLD prevalence has increased across all regions, with the largest growth in Australasia (29%) and East Asia (27%). In addition, marked regional disparities were observed in age-standardised death and DALY rates, with Central Asia exhibiting the highest health loss across the region. Age-stratified analyses revealed that the highest incidence occurred in individuals aged 20\u201324 years in 2023. MASLD burden followed an inverse U-shaped pattern with SDI, increasing in regions with lower SDI and decreasing in those above 0.62. Population growth and lifestyle changes were the primary drivers of MASLD in East Asia, while ageing significantly contributed to the rising burden in South Asia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MASLD is increasingly prevalent across the Asia-Pacific region, driven by ageing, population growth and epidemiological changes, with significant regional variations in the disease burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/egastro-2026-100369","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:25:18Z","timestamp":1774974318000},"page":"e100369","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Burden of metabolic dysfunction-associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023"],"prefix":"10.1136","volume":"4","author":[{"given":"Xiao-Dong","family":"Zhou","sequence":"first","affiliation":[{"name":"MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China"},{"name":"Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-Fen","family":"Chen","sequence":"additional","affiliation":[{"name":"Medical Care Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China"},{"name":"Institute of Aging, the Center for Geriatric Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Verona, Verona, Italy"},{"name":"Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"D Byrne","sequence":"additional","affiliation":[{"name":"Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton, and University of Southampton, Southampton General Hospital, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"},{"name":"Department of Precision Medicine, Biological Resource Center Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Muthiah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Up","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore"},{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-9069","authenticated-orcid":false,"given":"Wenhao","family":"Li","sequence":"additional","affiliation":[{"name":"Barts Liver Centre, Blizard Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, School of Medicine, Recep Tayyip Erdo\u011fan University, Rize, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology and Metabolism, Medical University Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-9410","authenticated-orcid":false,"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[{"name":"Medical Data Analytics Centre, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China"},{"name":"State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-2631","authenticated-orcid":false,"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[{"name":"MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China"},{"name":"Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"2026033109250560000_4.1.e100369.1","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0431"},{"key":"2026033109250560000_4.1.e100369.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155999"},{"key":"2026033109250560000_4.1.e100369.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2412865"},{"key":"2026033109250560000_4.1.e100369.4","doi-asserted-by":"crossref","first-page":"156575","DOI":"10.1016\/j.metabol.2026.156575","article-title":"Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region","volume":"179","author":"Zhang","year":"2026","journal-title":"Metabolism"},{"key":"2026033109250560000_4.1.e100369.5","doi-asserted-by":"crossref","unstructured":"Esposito M , Rimauro I , Frattolillo V , et al . MASLD in childhood as a multisystem health challenge beyond the liver. Trends Endocrinol Metab 2025. doi:10.1016\/j.tem.2025.10.001","DOI":"10.1016\/j.tem.2025.10.001"},{"key":"2026033109250560000_4.1.e100369.6","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention","volume":"21","author":"Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026033109250560000_4.1.e100369.7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S2468-1253(25)00188-8","article-title":"Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis","volume":"10","author":"Celsa","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026033109250560000_4.1.e100369.8","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100218","article-title":"Steatotic liver disease and cancer: from pathogenesis to therapeutic targets","volume":"3","author":"Yang","year":"2025","journal-title":"eGastroenterology"},{"key":"2026033109250560000_4.1.e100369.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-025-01199-y","article-title":"Cardiovascular-kidney-metabolic syndrome and MASLD: integrating medical perspectives","volume":"22","author":"Zhou","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"2026033109250560000_4.1.e100369.10","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2024-100115","article-title":"Mechanistic role of long non-coding RNAs in the pathogenesis of metabolic dysfunction-associated steatotic liver disease and fibrosis","volume":"2","author":"Wade","year":"2024","journal-title":"eGastroenterology"},{"key":"2026033109250560000_4.1.e100369.11","doi-asserted-by":"crossref","unstructured":"Zhou XD , Fan QY , Targher G , et al . MASLD as a Systemic Metabolic Disease: Expanding the Scope of Cardiovascular-Kidney-Metabolic (CKM) Syndrome. Sci China Life Sci 2025. doi:10.1007\/s11427-025-3193-9","DOI":"10.1007\/s11427-025-3193-9"},{"key":"2026033109250560000_4.1.e100369.12","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100196","article-title":"Key takeaways from the updated multidisciplinary European MASLD guidelines","volume":"3","author":"Horn","year":"2025","journal-title":"eGastroenterology"},{"key":"2026033109250560000_4.1.e100369.13","doi-asserted-by":"crossref","unstructured":"Zhou X-D , Chen Q-F , Fan Q-Y , et al . Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD. Hepatology 2025. doi:10.1097\/HEP.0000000000001645","DOI":"10.1097\/HEP.0000000000001645"},{"key":"2026033109250560000_4.1.e100369.14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026033109250560000_4.1.e100369.15","doi-asserted-by":"crossref","unstructured":"Younossi ZM , Paik JM , Lazarus JV , et al . Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data From Nine Countries. Clin Gastroenterol Hepatol 2025. doi:10.1016\/j.cgh.2025.09.002","DOI":"10.1016\/j.cgh.2025.09.002"},{"key":"2026033109250560000_4.1.e100369.16","article-title":"The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions","volume":"49","author":"Goh","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026033109250560000_4.1.e100369.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001487","article-title":"Organisation of primary health care systems in low- and middle-income countries: review of evidence on what works and why in the Asia-Pacific region","volume":"4","author":"Dodd","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2026033109250560000_4.1.e100369.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2024.11.016"},{"key":"2026033109250560000_4.1.e100369.19","doi-asserted-by":"crossref","first-page":"101338","DOI":"10.1016\/j.lanplh.2025.101338","article-title":"A centre of gravity: Asia-Pacific leadership in global food systems transformation","volume":"9","author":"Fernandez de Cordoba Farini","year":"2025","journal-title":"Lancet Planet Health"},{"key":"2026033109250560000_4.1.e100369.20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2024.08.011","article-title":"Association of food insecurity with MASLD prevalence and liver-related mortality","volume":"82","author":"Younossi","year":"2025","journal-title":"J Hepatol"},{"key":"2026033109250560000_4.1.e100369.21","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","article-title":"Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","author":"Hay","year":"2025","journal-title":"Lancet"},{"key":"2026033109250560000_4.1.e100369.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01330-3"},{"key":"2026033109250560000_4.1.e100369.23","unstructured":"GHDx . Global burden of disease study 2023 (GBD 2023) data resources. Available: https:\/\/ghdx.healthdata.org\/gbd-2023 [Accessed 29 Oct 2025]."},{"key":"2026033109250560000_4.1.e100369.24","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023","volume":"86","year":"2025","journal-title":"JACC"},{"key":"2026033109250560000_4.1.e100369.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01917-8"},{"key":"2026033109250560000_4.1.e100369.26","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jhep.2024.03.039","article-title":"Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both","volume":"81","author":"Zhou","year":"2024","journal-title":"J Hepatol"},{"key":"2026033109250560000_4.1.e100369.27","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2468-2667(19)30019-2","article-title":"Measuring population ageing: an analysis of the Global Burden of Disease Study 2017","volume":"4","author":"Chang","year":"2019","journal-title":"Lancet Public Health"},{"key":"2026033109250560000_4.1.e100369.28","doi-asserted-by":"crossref","first-page":"102791","DOI":"10.1016\/j.dsx.2023.102791","article-title":"The impact of global, regional, and national population ageing on disability-adjusted life years and deaths associated with diabetes during 1990-2019: A global decomposition analysis","volume":"17","author":"Zhang","year":"2023","journal-title":"Diabetes Metab Syndr"},{"key":"2026033109250560000_4.1.e100369.29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.14309\/ajg.0000000000002508","article-title":"A Study of Dietary Patterns Derived by Cluster Analysis and Their Association With Metabolic Dysfunction-Associated Steatotic Liver Disease Severity Among Hispanic Patients","volume":"119","author":"Zhang","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026033109250560000_4.1.e100369.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.06.036"},{"key":"2026033109250560000_4.1.e100369.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.06.017"},{"key":"2026033109250560000_4.1.e100369.32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2024.09.033","article-title":"Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study","volume":"82","author":"Ran","year":"2025","journal-title":"J Hepatol"},{"key":"2026033109250560000_4.1.e100369.33","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16220","article-title":"The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective","volume":"45","author":"Alabdul Razzak","year":"2025","journal-title":"Liver Int"},{"key":"2026033109250560000_4.1.e100369.34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.medj.2024.03.017","article-title":"An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease","volume":"5","author":"Zhang","year":"2024","journal-title":"Med"},{"key":"2026033109250560000_4.1.e100369.35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102848","article-title":"Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021","volume":"76","author":"Zhou","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2026033109250560000_4.1.e100369.36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.14309\/ajg.0000000000002749","article-title":"Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States","volume":"119","author":"Paik","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026033109250560000_4.1.e100369.37","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.2337\/dc24-1236","article-title":"Steatotic Liver Disease in Pediatric Obesity and Increased Risk for Youth-Onset Type 2 Diabetes","volume":"47","author":"Putri","year":"2024","journal-title":"Diabetes Care"},{"key":"2026033109250560000_4.1.e100369.38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.09.013","article-title":"Genetic and non-genetic drivers of histological progression and regression in MASLD","volume":"84","author":"Vilar-Gomez","year":"2026","journal-title":"J Hepatol"},{"key":"2026033109250560000_4.1.e100369.39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/HEP.0000000000001216","article-title":"Longitudinal response to standard of care in pediatric metabolic dysfunction-associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes","volume":"82","author":"Newton","year":"2025","journal-title":"Hepatology"},{"key":"2026033109250560000_4.1.e100369.40","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/HEP.0000000000001440","article-title":"Call to action-Pediatric MASLD requires immediate attention to curb health crisis","volume":"82","author":"Hartmann","year":"2025","journal-title":"Hepatology"},{"key":"2026033109250560000_4.1.e100369.41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2025.07.011","article-title":"Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness\/Fibrosis Progression and Prognostic Outcomes in MASLD","volume":"24","author":"Zhou","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026033109250560000_4.1.e100369.42","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMra2403308","article-title":"Noninvasive Assessment of Liver Fibrosis","volume":"393","author":"Castera","year":"2025","journal-title":"N Engl J Med"},{"key":"2026033109250560000_4.1.e100369.43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jhep.2025.08.017","article-title":"Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD","volume":"84","author":"Zhou","year":"2026","journal-title":"J Hepatol"},{"key":"2026033109250560000_4.1.e100369.44","doi-asserted-by":"crossref","unstructured":"Zhou X-D , Chen Q-F , Kim SU , et al . Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD. Clin Gastroenterol Hepatol 2025. doi:10.1016\/j.cgh.2025.10.003","DOI":"10.1016\/j.cgh.2025.10.003"},{"key":"2026033109250560000_4.1.e100369.45","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2025.06.020","article-title":"Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community","volume":"83","author":"Hansen","year":"2025","journal-title":"J Hepatol"},{"key":"2026033109250560000_4.1.e100369.46","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2025.02.044","article-title":"Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis","volume":"169","author":"Younossi","year":"2025","journal-title":"Gastroenterology"},{"key":"2026033109250560000_4.1.e100369.47","doi-asserted-by":"crossref","unstructured":"Zhou X-D , Lazarus JV , Krittanawong C , et al . Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart-liver co-management. Lancet Gastroenterol Hepatol 2026. doi:10.1016\/S2468-1253(25)00323-1","DOI":"10.1016\/S2468-1253(25)00323-1"},{"key":"2026033109250560000_4.1.e100369.48","article-title":"Pediatric MASLD in China: epidemiology, screening, diagnosis, and management","volume":"64","author":"Li","year":"2025","journal-title":"Lancet Reg Health West Pac"}],"container-title":["eGastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/egastro-2026-100369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:25:24Z","timestamp":1774974324000},"score":1,"resource":{"primary":{"URL":"http:\/\/egastroenterology.bmj.com\/lookup\/doi\/10.1136\/egastro-2026-100369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,31]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/egastro-2026-100369"],"URL":"https:\/\/doi.org\/10.1136\/egastro-2026-100369","relation":{},"ISSN":["2766-0125","2976-7296"],"issn-type":[{"value":"2766-0125","type":"print"},{"value":"2976-7296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}